Author Question: A patient with mania relapsed after discontinuing lithium. New orders are written to resume lithium ... (Read 84 times)

aabwk4

  • Hero Member
  • *****
  • Posts: 593
A patient with mania relapsed after discontinuing lithium. New orders are written to resume lithium twice daily and begin olanzapine (Zyprexa). The addition of olanzapine to the medication regimen will:
 
  a. minimize the side effects of lithium.
  b. bring hyperactivity under rapid control.
  c. enhance the antimanic actions of lithium.
  d. be used for long-term control of hyperactivity.

Question 2

This nursing diagnosis applies to a patient with mania: Imbalanced nutrition: less than body requirements related to insufficient caloric intake and hyperactivity as evidenced by 5-pound weight loss in 4 days. Select the most appropriate outcome.
 
  The patient will:
 
  a. ask staff for assistance with feeding within 4 days.
  b. drink six servings of a high-calorie, high-protein drink each day.
  c. consistently sit with others for at least 30 minutes at mealtime within 1 week.
  d. consistently wear appropriate attire for age and sex within 1 week while in the psychiatric unit.



bob

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

ANS: B
Manic symptoms are controlled by lithium only after a therapeutic serum level is attained. Because this takes several days to accomplish, a drug with rapid onset is necessary to reduce the hyperactivity initially. Antipsychotic drugs neither enhance lithium's antimanic activity nor minimize the side effects. Lithium is used for long-term control.

Answer to Question 2

ANS: B
High-calorie, high-protein food supplements will provide the additional calories needed to offset the patient's extreme hyperactivity. Sitting with others or asking for assistance does not mean the patient will eat or drink. The other indicator is unrelated to the nursing diagnosis.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library